Xiaheng Deng

865 total citations
33 papers, 682 citations indexed

About

Xiaheng Deng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaheng Deng has authored 33 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Xiaheng Deng's work include Cancer-related molecular mechanisms research (11 papers), Bladder and Urothelial Cancer Treatments (9 papers) and MicroRNA in disease regulation (9 papers). Xiaheng Deng is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Bladder and Urothelial Cancer Treatments (9 papers) and MicroRNA in disease regulation (9 papers). Xiaheng Deng collaborates with scholars based in China. Xiaheng Deng's co-authors include Qiang Lü, Xiao Yang, Jun Tao, Pengchao Li, Yidong Cheng, Xiaolei Zhang, Min Gu, Chengdi Yang, Haiwei Yang and Changjun Yin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Microbiology.

In The Last Decade

Xiaheng Deng

31 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaheng Deng China 13 517 458 121 63 52 33 682
Guokun Wang China 17 570 1.1× 428 0.9× 77 0.6× 144 2.3× 79 1.5× 36 848
Chenghao Wang China 11 357 0.7× 261 0.6× 71 0.6× 65 1.0× 106 2.0× 34 599
Yajun Xiao China 13 322 0.6× 186 0.4× 69 0.6× 149 2.4× 88 1.7× 53 564
Roy Ehrnström Sweden 13 339 0.7× 206 0.4× 82 0.7× 133 2.1× 183 3.5× 24 615
Ti‐Chun Chan Taiwan 14 255 0.5× 146 0.3× 104 0.9× 97 1.5× 103 2.0× 43 456
Yezhou Sun United States 6 358 0.7× 166 0.4× 61 0.5× 42 0.7× 21 0.4× 11 579
Sobeyda Gomez United States 4 358 0.7× 252 0.6× 79 0.7× 41 0.7× 213 4.1× 4 651
Annemarie M. van Oeveren‐Rietdijk Netherlands 11 306 0.6× 243 0.5× 51 0.4× 27 0.4× 27 0.5× 12 528
Shi Fu China 12 228 0.4× 128 0.3× 99 0.8× 128 2.0× 47 0.9× 56 459

Countries citing papers authored by Xiaheng Deng

Since Specialization
Citations

This map shows the geographic impact of Xiaheng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaheng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaheng Deng more than expected).

Fields of papers citing papers by Xiaheng Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaheng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaheng Deng. The network helps show where Xiaheng Deng may publish in the future.

Co-authorship network of co-authors of Xiaheng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaheng Deng. A scholar is included among the top collaborators of Xiaheng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaheng Deng. Xiaheng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Cheng, et al.. (2024). TFAP2A-activated ITGB4 promotes lung adenocarcinoma progression and inhibits CD4+/CD8+ T-cell infiltrations by targeting NF-κB signaling pathway. Translational Lung Cancer Research. 13(9). 2116–2138. 2 indexed citations
2.
Deng, Xiaheng, et al.. (2022). Cell Trajectory-Related Genes of Lung Adenocarcinoma Predict Tumor Immune Microenvironment and Prognosis of Patients. Frontiers in Oncology. 12. 911401–911401. 12 indexed citations
4.
Li, Peng, Xiao Yang, Wenbo Yuan, et al.. (2018). CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a. Cellular Physiology and Biochemistry. 46(4). 1606–1616. 125 indexed citations
5.
Li, Peng, Xiao Yang, Yidong Cheng, et al.. (2017). MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1. Cellular Physiology and Biochemistry. 41(3). 921–932. 81 indexed citations
6.
Li, Pengchao, Jun Tao, Xiaheng Deng, et al.. (2017). Extraperitoneal Laparoscopic Radical Nephroureterectomy and Lymph Node Dissection in Modified Supine Position. Urology. 107. 126–131. 7 indexed citations
7.
Yang, Xiao, Wenbo Yuan, Jun Tao, et al.. (2017). Identification of circular RNA signature in bladder cancer. Journal of Cancer. 8(17). 3456–3463. 28 indexed citations
8.
Liu, Jinliang, Gong Cheng, Haiwei Yang, et al.. (2016). Reciprocal regulation of long noncoding RNAs THBS4-003 and THBS4 control migration and invasion in prostate cancer cell lines. Molecular Medicine Reports. 14(2). 1451–1458. 33 indexed citations
9.
Li, Pengchao, Yidong Cheng, Xiaolei Zhang, et al.. (2016). MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK. OncoTargets and Therapy. Volume 9. 5091–5099. 29 indexed citations
10.
Li, Pengchao, Xiaolei Zhang, Xiaheng Deng, et al.. (2016). AB143. Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin. Translational Andrology and Urology. 5(S1). AB143–AB143.
11.
Lü, Qiang, Yidong Cheng, Xiaheng Deng, et al.. (2015). Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis. OncoTargets and Therapy. 8. 2089–2089. 12 indexed citations
12.
Zhao, Ruizhe, Kang Liu, Zhengkai Huang, et al.. (2015). Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population. PLoS ONE. 10(6). e0128771–e0128771. 17 indexed citations
13.
Li, Pengchao, Jun Tao, Xiao Yang, et al.. (2015). Serum metabolomic analysis of human upper urinary tract urothelial carcinoma. Tumor Biology. 36(10). 7531–7537. 9 indexed citations
14.
Cheng, Yidong, Xiao Yang, Xiaheng Deng, et al.. (2015). MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1. Tumor Biology. 36(10). 8015–8023. 42 indexed citations
15.
Deng, Xiaheng, Xiao Yang, Yidong Cheng, et al.. (2015). GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy. Scientific Reports. 5(1). 14000–14000. 12 indexed citations
16.
Tao, Jun, Xiao Yang, Pengchao Li, et al.. (2015). Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection. Molecular Medicine Reports. 12(5). 6752–6760. 17 indexed citations
17.
Yang, Xiao, Pengchao Li, Jun Tao, et al.. (2014). Association betweenNFKB1−94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis. International Journal of Genomics. 2014. 1–8. 26 indexed citations
18.
Deng, Xiaheng, Yidong Cheng, Xiao Yang, et al.. (2014). Meta-Analysis Reveals a Lack of Association between UGT2B17 Deletion Polymorphism and Tumor Susceptibility. PLoS ONE. 9(5). e96812–e96812. 2 indexed citations
19.
Yang, Xiao, Yidong Cheng, Pengchao Li, et al.. (2014). A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis. Tumor Biology. 36(1). 383–391. 91 indexed citations
20.
Deng, Xiaheng, et al.. (2013). MiR-21 involve in ERK-mediated upregulation of MMP9 in the rat hippocampus following cerebral ischemia. Brain Research Bulletin. 94. 56–62. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026